The specific biological agents and toxins currently on the USG DURC-PEPP Policy Category 1 List are shown under the expandable headings below. It is important to note that the Category 1 List is subject to change depending upon amendments to the source documents, which are identified further below on this page.
- Bacillus anthracis
- Bacillus anthracis Pasteur strain
- Bacillus cereus Biovar anthracis
- Bartonella
- Brucella including B. abortus, B. melitensis, B. Suis
- Burkholderia mallei
- Burkholderia pseudomallei
- Clostridium botulinum and neurotoxin-producing species of Clostridium
- Coniothyrium glycines
- Coxiella burnetii
- Francisella tularensis
- Mycoplasma capricolum
- Mycoplasma mycoides
- Orientia tsutsugamushi
- Pasteurella multocida type B -"buffalo" and other virulent strains
- Ralstonia solanacearum
- Rathayibacter toxicus
- Rickettsia akari, R. australis, R. canada, R. conorii, R. prowazekii, R. rickettsii, R, siberica, R. typhi (R.mooseri)
- Sclerophthora rayssiae
- Synchytrium endobioticum
- Xanthomonas oryzae
- Yersinia pestis
- African swine fever virus
- Alphaviruses (Togaviruses) - Group A Arboviruses
- Chikungunya virus except the vaccine strain 181/25
- Semliki Forest virus
- St. Louis encephalitis virus
- Arenaviruses
- Flexal virus
- Lymphocytic choriomeningitis virus (LCM) (neurotropic strains)
- Avian influenza virus [included here as a veterinary select agent in 9 CFR 121.3. Low pathogenicity strains are excluded]
- Bunyaviruses
- Hantaviruses, including Hantaan virus
- Classical swine fever virus
- Coronaviruses
- Middle East respiratory syndrome coronavirus (MERS-CoV)
- Crimean-Congo hemorrhagic fever virus
- Eastern equine encephalitis virus
- Ebolavirus
- Flaviviruses - Group B Arboviruses
- Japanese encephalitis virus except strain SA 14-14-2
- Koutango virus
- Louping Ill virus
- Murray Valley encephalitis virus
- Powassan virus
- Rocio virus
- Wesselsbron virus
- West Nile virus
- Yellow fever virus
- Foot-and-mouth disease virus
- Goat pox virus
- Hemorrhagic fever agents and viruses as yet undefined
- Hendra virus
- Herpesvirus simiae (herpes B or monkey B virus)
- Lassa fever virus
- Lujo virus
- Lumpy skin disease virus
- Marburg virus
- Mpox virus Clade I
- Mpox virus clade I/II chimeric viruses resulting from any deliberate manipulation of clade II to incorporate nucleic acids coding for clade I virulence factors
- Newcastle disease virus
- 1918-1919 H1N1 including reconstructed replication competent forms of the 1918 pandemic influenza virus containing any portion of the coding regions of all eight gene segments (Reconstructed 1918 Influenza virus)
- Nipah virus
- Orthomyxoviruses
- Human influenza A virus H2N2 (1957-1968)
- Highly pathogenic avian influenza A virus H5Nx strains within the Goose/Guangdong/96-like H5 lineage (e.g., H5N1, H5N6, H5N8, etc.)
- Peste des petits ruminants virus
- Prions
- Transmissible spongiform encephalopathy (TSE) agents (e.g., Creutzfeldt-Jakob disease and kuru agents)
- Rift Valley fever virus
- Rinderpest virus
- Severe acute respiratory syndrome coronavirus (SARS-CoV) SARS-CoV/SARS-CoV-2 chimeric viruses resulting from any deliberate manipulation of SARS-CoV-2 to incorporate nucleic acids coding for SARS-CoV virulence factors
- Sheep pox virus
- South American Haemorrhagic Fever viruses
- Chapare virus
- Guanarito virus
- Junín virus
- Machupo virus
- Sabía virus
- Swine vesicular disease virus
- Tick-borne encephalitis complex (flavi) viruses
- Absetterov
- Central European encephalitis
- Far Eastern subtype
- Hanzalova
- Hypr
- Kyasanur Forest disease virus
- Kumlinge
- Omsk hemorrhagic fever virus
- Siberian subtype
- Variola major virus (Smallpox virus)
- Variola minor virus (Alastrim)
- Venezuelan equine encephalitis virus
- Abrin
- Botulinum neurotoxins
- Conotoxins (Short, paralytic alpha conotoxins containing the following amino acid sequence X1CCX2PACGX3X4X5X6CX7)
- Diacetoxyscirpenol
- Ricin
- Saxitoxin
- Staphylococcal enterotoxins (subtypes A, B, C, D, E)
- T-2 toxin
- Tetrodotoxin
- Any attenuated pathogen or vaccine strain that is currently excluded from the Select Agent Regulations that exhibits the recovery of virulence at or near the wild-type
- Agents added during future updates to the USG DURC-PEPP policy
- Biological agents affecting humans that have not been assigned a Risk Group in the NIH Guidelines but are agents recommended to be handled at BSL3 or BSL4 per the guidance in the Biosafety in Microbiological and Biomedical Laboratories (BMBL):
- Araguari virus
- Arenaviruses
- Allpahuayo, Bear Canyon, Big Brushy Tank, Cupixi, Gairo, Loei River, Luna, Lunk, Mariental, Merino Walk, Mobala, Mopeia, Morogoro, Okahandja, Oliveros, Pirital, Solwezi, Wēnzhōu, and Whitewater Arroyo
- Bovine ephemeral fever virus
- Orthobunyaviruses
- Akabane, Douglas, Ngaric, and Xingu
- Orthonairoviruses
- Artashat, Dugbe, Issyk-Kul, Kupe, Nairobi sheep disease
- Phleboviruses
- Bhanja, Escharte, Heartland, Hunter Island, Malsoor, Morolillo, Salobo, Severe fever with thrombocytopenia syndrome
- Reoviruses
- African horse sickness, Banna, Bluetongue (exotic serotypes), Peruvian horse sickness, Yunnan orbivirus
- Somone virus
- South Bay virus
- Sripur virus
- Coccidioides immitis
- Coccidioides posadasii
- Histoplasma capsulatum and Histoplasma capsulatum var. Duboisii
- Human immunodeficiency viruses (HIV) types 1 and 2
- Human T-lymphotropic virus 1 (HTLV) types 1 and 2
- Mpox virus Clade II, unless containing nucleic acids coding for clade I Mpox virus virulence factors
- Mycobacterium bovis, Mycobacterium tuberculosis
- Simian immunodeficiency virus (SIV)
- Vesicular stomatitis virus
Source Documents
The biological agents, viruses, and pathogens on the DURC-PEPP Policy Category 1 list include:
- All Select Agents and Toxins controlled by Federal Select Agent Regulations, including those at amounts below the Permissible Toxin Amounts. For purposes of the DURC-PEPP Policy, there are no exempt quantities for these agents and toxins. Refer to the Select Agents and Toxins list for any relevant strain exclusions.
- All Risk Group 4 pathogens listed in Appendix B-IV of the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines). Risk Group 4 agents are likely to cause serious or lethal human disease for which preventive or therapeutic interventions are not usually available. Refer to Appendix B-IV of the NIH Guidelines for any relevant strain exclusions.
- A subset of Risk Group 3 pathogens listed in Appendix B-III of the NIH Guidelines (see Exceptions). Risk Group 3 agents are associated with serious or lethal human disease for which preventive or therapeutic interventions may be available, but are not controlled by the Select Agent Regulations. Refer to Appendix B-III of the NIH Guidelines for any relevant strain exclusions
- Other biological agents affecting humans that have not been assigned a Risk Group in the NIH Guidelines, and are recommended to be handled at BSL3 or BSL4 per CDC guidance in the Biosafety in Microbiological and Biomedical Laboratories (BMBL).
- Biological agents added during future updates to the USG Implementation Guidance.
Questions?
For questions or more information about the DURC-PEPP policy or Category 1 and Category 2 research, email the IBC at [email protected].
Posted on: Monday, February 17, 2025 - 12:35